Molecular cloning of multiple forms of the ovine B7-2 (CD86) costimulatory molecule

Veterinary Immunology and Immunopathology

Volumn 114, Issue 1-2, 2006, Pages 149-158

  Terzo, Esteban A ^a   de Villarreal, Maider Pérez ^a   Mick, Virginie ^a   Muñoz, Francisco ^a   Amorena, Beatriz ^a   de Andrés, Damian ^a   Pérez de la Lastra, José M ^a  

^a PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

B7 1; B7 2; CD antigen expression; CD80; CD86; Costimulatory; Isoforms; Ovine; Sheep

Indexed keywords

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOSTIMULATION; MEMBRANE TRANSPORT; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SHEEP; T LYMPHOCYTE ACTIVATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD86; BASE SEQUENCE; CLONING, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SHEEP;

BOS TAURUS; MAMMALIA; OVIS; OVIS ARIES; SUS SCROFA;

EID: 33748776562     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2006.08.003     Document Type: Article

References (23)

1. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L., and Somoza C. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366 (1993) 76-79
2. Bajorath J., Peach R.J., and Linsley P.S. Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci. 3 (1994) 2148-2150
3. Borriello F., Oliveros J., Freeman G.J., Nadler L.M., and Sharpe A.H. Differential expression of alternate mB7-2 transcripts. J. Immunol. 155 (1995) 5490-5497
4. Bour-Jordan H., and Blueston J.A. CD28 function: a balance of costimulatory and regulatory signals. J. Clin. Immunol. 22 (2002) 1-7
5. Carreno B.M., and Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Ann. Rev. Immunol. 20 (2002) 29-53
6. Chen A., Meyerson H.J., Salvekar A., and Tykocinski M.L. Non-glycosylated human B7-1 (CD80) retains the capacity to bind its counter-receptors. FEBS Lett. 428 (1998) 127-134
7. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Gribben J.G., Ng J.W., Kim J., Goldberg J.M., Hathcock K., Laszlo G., et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178 (1993) 2185-2192
8. Freeman G.J., Gribben J.G., Boussiotis V.A., Ng J.W., Restivo Jr. V.A., Lombard L.A., Gray G.S., and Nadler L.M. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262 (1993) 909-911
9. Greenfield E.A., Nguyen K.A., and Kuchroo V.K. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18 (1998) 389-418
10. Harris N.L., and Ronchese F. The role of B7 costimulation in T-cell immunity. Immunol. Cell Biol. 77 (1999) 304-311
11. Hollsberg P., Scholz C., Anderson D.E., Greenfield E.A., Kuchroo V.K., Freeman G.J., and Hafler D.A. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4. J. Immunol. 159 (1997) 4799-4805
12. Inobe M., Aoki N., Linsley P.S., Ledbetter J.A., Abe R., Murakami M., and Uede T. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. Int. J. Immunol. (1996) 582-588
13. Jeannin P., Magistrelli G., Aubry J.P., Caron G., Gauchat J.F., Renno T., Herbault N., Goetsch L., Blaecke A., Dietrich P.Y., Bonnefoy J.Y., and Delneste Y. Soluble CD86 is a costimulatory molecule for human T lymphocytes. Immunity 13 (2000) 303-312
14. Jellis C.L., Wang S.S., Rennert P., Borriello F., Sharpe A.H., Green N.R., and Gray G.S. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics 42 (1995) 85-89
15. Kim J.J., Nottingham L.K., Wilson D.M., Bagarazzi M.L., Tsai A., Morrison L.D., Javadian A., Chalian A.A., Agadjanyan M.G., and Weiner D.B. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine 16 (1998) 1828-1835
16. Magistrelli G., Caron G., Gauchat J.F., Jeannin P., Bonnefoy J.Y., and Delneste Y. Identification of an alternatively spliced variant of human CD86 mRNA. Biochem. Biophys. Res. Commun. 280 (2001) 1211-1215
17. Mornex J.F. The sheep, model for human lung pathology. Rev. Praticien 53 (2003) 241-244
18. Santra S., Barouch D.H., Jackson S.S., Kuroda M.J., Schmitz J.E., Lifton M.A., Sharpe A.H., and Letvin N.L. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. J. Immunol. 165 (2000) 6791-6795
19. Subudhi S.K., Alegre M.L., and Fu Y.X. The balance of immune responses: costimulation verse coinhibition. J. Mol. Med. 83 (2005) 193-202
20. Terzo E.A., Alzueta M., Amorena B., de Andres D.F., and de la Lastra J.M. Molecular cloning and mRNA tissue-expression of two isoforms of the ovine costimulatory molecule CD80 (B7-1). Vet. Immunol. Immunopathol. 103 (2005) 9-19
21. Villinger F., Bostik P., Mayne A., King C.L., Genain C.P., Weiss W.R., and Ansari A.A. Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules. Immunogenetics 53 (2001) 315-328
22. Yang S., Sellins K.S., Powell T., Stoneman E., and Sim G.K. Novel transcripts encoding secreted forms of feline CD80 and CD86 costimulatory molecules. Vet. Immunol. Immunopathol. 81 (2001) 15-21
23. Zhang X., Schwartz J.C., Almo S.C., and Nathenson S.G. Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. Protein Expr. Purif. 25 (2002) 105-113